New antiretroviral agents.
Gallant
J E
JE
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000225:Adenine / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D002219:Carbamates; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D004148:Dioxolanes; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000145:classification / Q000493:pharmacokinetics; D000068679:Emtricitabine; D005663:Furans; D006151:Guanosine / Q000031:analogs & derivatives*; D023581:HIV Fusion Inhibitors / Q000008:administration & dosage / Q000145:classification / Q000493:pharmacokinetics; D006801:Humans; D007093:Imidazoles; D009842:Oligopeptides; D010755:Organophosphates; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011355:Prodrugs; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000145:classification / Q000493:pharmacokinetics; D011725:Pyridines; D011753:Pyrones; D011799:Quinazolines; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D013457:Sulfur Compounds; D000068698:Tenofovir
D019380:Anti-HIV Agents; D002219:Carbamates; C430648:DPC 083; D004148:Dioxolanes; D015507:Drugs, Investigational; D005663:Furans; D023581:HIV Fusion Inhibitors; D007093:Imidazoles; D009842:Oligopeptides; D010755:Organophosphates; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011355:Prodrugs; D011480:Protease Inhibitors; D011725:Pyridines; D011753:Pyrones; D011799:Quinazolines; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D013457:Sulfur Compounds; C098394:dioxolane guanosine; D003841:Deoxycytidine; D006151:Guanosine; D000069446:Atazanavir Sulfate; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine; C433874:capravirine; C426859:fosamprenavir; C107201:tipranavir